Skip to main content

Sleep-disordered breathing in ischemic cardiomyopathy and
hypertensive heart failure patients

مؤلف البحث
Suzan Salamaa, Amany Omara, Yasser Ahmeda, Mahmoud Abd El Sabourb,
Mohamed Ismail Seddikc, Doaa Magdya
مجلة البحث
Egyptian Journal of Bronchology
المشارك في البحث
الناشر
Doaa Magdya
تصنيف البحث
2
عدد البحث
Egyptian Journal of Bronchology 2017 11:154–160
موقع البحث
NULL
سنة البحث
2017
صفحات البحث
154–160
ملخص البحث

Aims The aims of this study are to (a) detect the effect of
different types of heart diseases [ischemic, cardiomyopathy,
hypertensive heart failure (HF)] on the association with sleep
disorders, and to (b) identify the relationship between
Cheyne–Stokes respiration (CSR) and left ventricular
dysfunction.
Materials and methods In a cross-sectional study involving
100 HF patients, we performed echocardiography and a fullnight
attended polysomnography for all patients.
Results In all, 47.9% of patients with ischemic heart disease
had obstructive sleep apnea (OSA), whereas 37.5% had
central sleep apnea (CSA). OSA was highly prevalent in
patients with hypertensive heart disease (79.2%). On the
other hand, 50.0% patients with dilated cardiomyopathy
(DCM) had CSA, whereas 39.3% had OSA. Patients with
DCM had a significant increase in the central apnea index
(11.05±9.19 events/h), as well cycle length of CSR (68.14
±13.26 s), as compared with other groups. There was an
inverse increase of cycle length with reduction in left
ventricular ejection fraction (LVEF) (LVEF≥50% had a cycle
length of 41.55±10.84 s, whereas those with LVEF≤30% had
a longer mean cycle length of 69.23±18.09 s).
Conclusion Sleep-disordered breathing is a common
disorder in different groups of HF. OSA was prevalent in
ischemic and hypertensive heart disease, whereas CSA was
prevalent in DCM. There was a significant increase in cycle
length of CSR with a reduction in LVEF.